Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmology News
Sight Sciences awarded $34 million in patent infringement case against Alcon
Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a press release.
VIDEO: Iheezo demonstrates long-lasting efficacy
BOSTON — In this Healio Video Perspective from the ASCRS meeting, William F. Wiley, MD, ABO, discusses his positive experience using Iheezo, a preservative-free ocular anesthetic for anterior segment surgery.
FDA approves preservative-free version of Lumify redness-reliever eye drops
The FDA has approved Lumify Preservative Free eye drops for the treatment of ocular redness due to minor eye irritations, according to a press release from manufacturer Bausch + Lomb.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Tolerance to refractive error with Tecnis Odyssey similar to monofocal lens
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Daniel H. Chang, MD, ABO, discusses tolerance to refractive error with the Tecnis Odyssey IOL.
Vision impairment limits access to digital technology in older adults
A study conducted on a nationally representative sample of older adults showed that access to digital technology is hampered by vision impairment, potentially limiting access to telehealth.
VIDEO: IRIS Registry data show safety, efficacy of Dextenza
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Steven M. Silverstein, MD, FACS, ABO, discusses IRIS Registry data related to Dextenza.
VIDEO: Notable features available with Teneo excimer laser platform
BOSTON — In this Healio Video Perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses the Teneo excimer laser platform.
Dagny Zhu, MD, on how physicians can establish a social media brand
Yari Mitchell has questions for Sumit Garg, MD: On integrating new tech and AI
VIDEO: Phase 3 clinical trial underway for pterygium eye drop
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Abu Abraham, MD, of Cloudbreak Pharma, and John A. Hovanesian, MD, FACS, discuss developments in the treatment of pterygium.
-
Headline News
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
April 29, 20243 min read -
Headline News
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
April 29, 20242 min read -
Headline News
FDA approves generic over-the-counter naloxone nasal spray
April 29, 20241 min read
-
Headline News
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
April 29, 20243 min read -
Headline News
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
April 29, 20242 min read -
Headline News
FDA approves generic over-the-counter naloxone nasal spray
April 29, 20241 min read